[Polychemotherapy of small-cell lung cancer]. 1983

K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa

UI MeSH Term Description Entries
D008130 Lomustine An alkylating agent of value against both hematologic malignancies and solid tumors. CCNU,Belustine,Cecenu,CeeNU,NSC-79037,NSC 79037,NSC79037
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009365 Neoplasm Regression, Spontaneous Disappearance of a neoplasm or neoplastic state without the intervention of therapy. Neoplasm Remission, Spontaneous,Remission, Spontaneous Neoplasm,Regression, Spontaneous Neoplasm,Spontaneous Neoplasm Regression,Spontaneous Neoplasm Remission
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
September 1993, Lancet (London, England),
K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
September 1993, Lancet (London, England),
K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
September 1993, Lancet (London, England),
K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
September 1993, Lancet (London, England),
K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
January 1983, Voprosy onkologii,
K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
July 1976, Cancer treatment reports,
K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
January 1986, Cancer chemotherapy and pharmacology,
K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
January 1977, Cancer treatment reports,
K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
January 1995, Medicinski arhiv,
K Krawczyk, and M Krochmal, and M Pawlicki, and J Kulpa
July 1993, Lancet (London, England),
Copied contents to your clipboard!